Multiple Sclerosis Trial, Recruiting NCT06495138 Sponsor: Emory University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06495138
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed by a neurologist with either primary progressive or relapsing-remitting multiple sclerosis (MS), according to specific recognised medical guidelines, OR you are a healthy volunteer with no MS or related neurological conditions
  • You can speak and understand English fluently
  • If you have MS, you currently experience dizziness, balance problems, and/or have had at least two falls in the past 12 months (based on what you report yourself)

Who may not be able to join:

  • You have an early or uncertain form of MS that has not yet fully developed into a confirmed diagnosis (confirm with trial site)
  • Your MS symptoms have been getting worse in the last 60 days
  • You have changed your MS immune-related medication in the last 60 days
  • You feel that memory or thinking difficulties affect your ability to manage everyday tasks on your own
  • Your blood pressure at rest is too high (above 180/90 mmHg)
  • Your vision, even with glasses or contact lenses, is significantly poor (confirm with trial site)
  • You have a notable eye alignment problem, such as a lazy eye or squint, of a certain degree
  • You have a condition where your eyes have difficulty focusing on close objects together (confirm with trial site)
  • You have a specific type of eye movement problem related to the nerve pathways in the brain (confirm with trial site)
  • You have been diagnosed with vestibular migraine (a type of migraine that causes dizziness)
  • You have a significant bone or joint condition that limits movement in your neck or affects the way you walk
  • You are currently pregnant or think you may become pregnant during the study
  • You are currently receiving therapy specifically for dizziness or balance problems

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Colin Grove, PT, MS, DPT, PhD, Emory University

Phone: (404) 712-8685

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 April 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Composite VOR gain (cVOR gain)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov